Concomitant glucose-dependent insulinotropic receptor (GIPR) and glucagon-like peptide-1 receptor (GLP1R) agonism stimulates TG-rich lipoprotein metabolism and attenuates atherosclerosis development.
Saved in:
| Title: | Concomitant glucose-dependent insulinotropic receptor (GIPR) and glucagon-like peptide-1 receptor (GLP1R) agonism stimulates TG-rich lipoprotein metabolism and attenuates atherosclerosis development. |
|---|---|
| Authors: | Modder, M.1 (AUTHOR), Van Eenige, R.1 (AUTHOR), Ying, Z.1 (AUTHOR), Qu, H.2 (AUTHOR), Coskun, T.2 (AUTHOR), Kooijman, S.1 (AUTHOR), Rensen, P.C.N.1 (AUTHOR) |
| Source: | Atherosclerosis (00219150). Aug2021, Vol. 331, pe12-e12. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00219150 |
|---|---|
| DOI: | 10.1016/j.atherosclerosis.2021.06.039 |
